Request Deal Involvement

Concordia Healthcare completed the acquisition of Amdipharm Mercury from Cinven for $3.5bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Rothschild & Co

financial advisors

Rothschild & Co

Deloitte

financial advisors

Deloitte

Clifford Chance

legal advisors

Clifford Chance

Jones Day

legal advisors

Jones Day

Torys

legal advisors

Torys

KPMG

financial advisors

KPMG

Jefferies & Company

financial advisors

Jefferies & Company

PricewaterhouseCoopers

financial advisors

PricewaterhouseCoopers

Fasken

legal advisors

Fasken

Simmons & Simmons

legal advisors

Simmons & Simmons

Sullivan & Cromwell

legal advisors

Sullivan & Cromwell

Ernst & Young

financial advisors

Ernst & Young

Goldman Sachs

financial advisors

Goldman Sachs

or

Principals

AMDIPHARM MERCURY LTD

target

AMDIPHARM MERCURY LTD

CINVEN LTD

vendor

CINVEN LTD

ADVANZ PHARMA CORP

bidder

ADVANZ PHARMA CORP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Concordia Healthcare completed the acquisition of Amdipharm Mercury from Cinven for $3.5bn.